Related Experiment Video
Updated: Jan 9, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
[Presentation of PASCA, a day hospital dedicated to multidisciplinary cancer survivorship assessment]
Arnaud Morel1, Béatrice Fervers1, Romain Buono1
1Département prévention cancer environnement, centre Léon Bérard, 28, rue Laennec, 69008 Lyon, France.
Abstract:
The number of patients in long-term remission after cancer is steadily increasing. In France, 3.8 million people are living with or cured of cancer. Five years after diagnosis, 63.5% still report sequelae, including pain, fatigue, or psychosocial disorders. This article describes the implementation of PASCA (Care Pathway during Cancer), a day hospital dedicated to survivorship care. Opened at the Comprehensive Cancer Center Léon Bérard in Lyon in November 2023, the program offers a half-day multidisciplinary assessment: physical fitness evaluation, general practice consultation, and nursing intervention with paraclinical tests and educational actions. Assessments initiated the management of frequent but often neglected complications, such as cognitive disorders (53% of patients), musculoskeletal disorders (38%), mood disorders (31%), and sexual health issues (36%), among others. They resulted in at least one medical prescription in more than 99% of cases. These findings highlight the value of a dedicated survivorship pathway to support primary care. A prospective evaluation is needed to measure actual benefits in terms of quality of life, prevention and reduction of sequelae. If confirmed, the PASCA program could represent a concrete response to the objectives of the French 10-Year Cancer Control Strategy and pave the way for harmonized survivorship care at the national level.
Related Concept Videos
Cancer Survival Analysis
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Restorative Care
Peripheral Artery Disease III: Interprofessional Care
Cancer Prevention
Some...

